Comparison Chart Armata Pharmaceuticals, Inc.
Stocks
ARMP
US04216R1023
Biotechnology & Medical Research
|
Market Closed -
NYSE
16:00:00 2026-10-16 EDT
|
5-day change | 1st Jan Change | ||
| 3.370 USD | +9.06% |
|
-7.16% | -46.34% |
| 09-14 | Armata Pharma Shares Rise on FDA Breakthrough Therapy Designation for Antibacterial Treatment | DJ |
| 09-14 | Armata Pharmaceuticals' AP-SA02 Gets FDA Breakthrough Therapy Designation | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| ARMATA PHARMACEUTICALS, INC. | Bio Therapeutic Drugs | +9.06% | -7.16% | -46.34% | -0.88% | -2.32% | 125M |
-
|
-
|
-
|
- Stock Market
- Stocks
- ARMP Stock
- Charts Armata Pharmaceuticals, Inc.
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
